Expert consensus on radiotherapy combined with immunotherapy for esophageal cancer(2024 edition)  

作　　者：Professional Committee of Radiation Oncology China Anti-Cancer Association Branch of Radiation Oncology Chinese Medical Association Branch of Radiation Oncology TreatmentPhysician Chinese Medical Doctor Association Qingsong Pang Jun Wang Zhouguang Hui Wencheng Zhang 

机构地区：[1]不详 [2]Tianjin Medical University Cancer Institute&Hospital,Tianjin 300060,China [3]the Fourth Hospital of Hebei Medical University,Shijiazhuang 050011,China [4]National Cancer Center,National Clinical Research Center for Cancer,Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China [5]Tianjin Medical University Cancer Hospital,China

出　　处：《Radiation Medicine and Protection》2024年第2期59-67,共9页放射医学与防护（英文）

摘　　要：Radiotherapy represents an essential treatment approach for esophageal cancer.Over recent years,immunotherapy combined with chemotherapy has become the first-line standard treatment for patients with advanced esophageal cancer.Several phase III studies on immunotherapy combined with radiotherapy for locally advanced esophageal cancer are currently underway.Sufficient evidence-based medical data are urgently needed to support the integration of immunotherapy and chemoradiotherapy as a new treatment strategy for patients with locally advanced esophageal cancer.This consensus,formulated based on the latest study results,in-depth research,and thorough discussions,provides a comprehensive set of recommendations.The document extensively covers treatment strategies and evaluation methods for radiotherapy combined with immunotherapy across patients with operable esophageal cancer,inoperable locally advanced esophageal cancer,and advanced esophageal cancer.Moreover,common complications and radiation-related issues associated with radiotherapy combined with immunotherapy are discussed,serving as clinical guidance.Our expert group comprised members from the Professional Committee of Radiation Oncology,China Anti-Cancer Association,the Branch of Radiation Oncology,Chinese Medical Association,and the Branch of Radiation Oncology Treatment Physician,Chinese Medical Doctor Association.

关 键 词：Esophageal squamous cell carcinoma Esophageal adenocarcinoma IMMUNOTHERAPY CHEMORADIOTHERAPY RADIOTHERAPY Expert consensus 

分 类 号：R730.55[医药卫生—肿瘤]